Skip to main content

Table 3 Effect of Matrine salvianolic acid B salt on HA, LN and Hyp in rats

From: Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis

Treatment

Doses

(mg/kg)

HA (ng/ml)

LN (ng/ml)

HyP (ng/ml)

Normal control

——

213.46 ± 21.62

85.39 ± 3.98

16.38 ± 1.30

CCl4

——

328.71 ± 18.42##

109.93 ± 18.16##

32.34 ± 6.41##

Matrine+ CCl4

50

292.49 ± 30.73*

94.79 ± 19.24*

27.14 ± 1.58**

Salvianolic acid B+ CCl4

150

290.66 ± 53.77*

88.36 ± 19.44**

22.25 ± 1.88**

 

25

289.88 ± 27.00*

99.79 ± 23.42

19.71 ± 1.52**bc

Matrine salvianolic acid B Salt+ CCl4

50

276.77 ± 47.19**

85.61 ± 14.21**

19.14 ± 1.86**bd

 

100

264.70 ± 49.62**

81.61 ± 16.22**a

18.65 ± 1.94**bd

Fu fang bie jia ruan gan pian+ CCl4

780

299.76 ± 33.99

97.37 ± 15.35*

18.86 ± 1.79**

  1. Data is expressed as the mean±SD (n = 12).
  2. ##p < 0.01 vs. the normal control group; *p < 0.05, **p < 0.01 vs. the CCl4-treated group;
  3. ap < 0.05, bp < 0.01 vs. the Matrine group; cp < 0.05, dp < 0.01 vs. the Salvianolic acid B group.